APOA1 and glioblastoma: In our previous study, the intratumoral injection of ADV-ApoA1 was shown to reprogram the lipid metabolism of glioblastoma multiforme (GBM), restore TAMs’ phagocytosis, and reactivate T cell anti-tumor immunity.